Abstract
Mixed micelles for MRA are multicomponent systems containing a phospholipid, a biocompatible non-ionic surfactant (e.g. Synporonic(k) F-108) and a lipophilic gadolinium complex. A variety of lipophilic gadolinium complexes were designed taking into account features such as: (i) nature of ligand (cyclic versus acyclic); (ii) lipophilic moiety; (iii) global charge of the complex; and (iv) nature of bond connecting the complex to the lipophilic moiety. All the lipophilic gadolinium complexes after formulation as mixed micelles show high relaxivities in water and in blood (rat). Mixed micelles containing gadolinium complexes bearing only one aliphatic chain cannot be used as MRA contrast agents because they have a high haemolytic effect. Furthermore, in rats they are quickly eliminated from the blood stream. These drawbacks are completely circumvented using gadolinium complexes bearing two aliphatic chains. Mixed micelles containing such complexes show high relaxivities. no haemolytic effect and long blood permanence. This makes them promising candidates as MRA contrast agents. However, elimination, which occurs exclusively through the liver, is not complete, even after 7 days. Complexes containing labile (e.g. ester) bonds between the lipophilic moieties and the chelate subunit are eliminated through both the liver and the kidneys. However, elimination is stiil not complete after 7 days.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Li D, Zheng J. Bae KT, Woodard PK, Haacke EM. Contrast-enhanced magnetic resonance imaging of the coronary arteries. Invest Radiol 1998;33:578–86.
Mühler A. The future of contrast-enhanced magnetic resonance angiography. Are blood pool agents needed? Invest Radiol 1998;33:709–14.
Mühler A. Assessment of myoeardial perfusion using contrast-enhanced MR imaging: Current status and future developments. MAGMA 1995;3:21–33.
Lauffer RB. Parmelee DJ, Dunham SU, Ouellet HS. Dolan RP. Witte S, McMurry TJ, Walovitch RC. MS-325: albumin-targeted contrast agent for MR angiography. Radiology 1998;207:529–38.
Wallace RA, Haar JP, Miller DB, Woulfe SR, Polta JA. Galen KP. Hynes MR. Adzamli K. Synthesis and preliminary evaluation of MP-2269: a novel, nonaromatic small-molecule bloodpool MR contrast agent. Magn Reson Med 1998;40:733–9.
Dong Q, Hurst DR, Weinmann HJ, Chenevert TL, Londy FJ, Prince MR. Magnetic resonance angiography with Gadomer-17. An animal study original investigation. Invest Radiol 1998;33:699–708.
Ladd DL, Hollister R, Peng X. Wei D, Wu G, Delecki D, Snow RA, Toner JL, Kellar K, Eck J, Desai VC, Raymond G. Kinter LB, Desser TS, Rubin DL. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis and properties. Bioconjugate Chem 1999;10:361–70.
Unger EC, Shen D-K, Fritz TA. Status of liposomes as MR contrast agents. J Magn Reson Imag 1993;3:195–8.
Tournier H. Hyacinthe R, Schneider M. Gadolinium-containing mixed micelles formulations: a new class of blood pool MRI/ MRA contrast agents, Acad Radiol (in press).
Ranganathan RS, Marinelli ER, Pillai R. Tweedle MF. Aromatic amide compounds and metal chelates thereof. PCT Int Appl WO95/27705, 1995;October 19.
Anelli PL, Fedeli F, Gazzotti O, Lattuada L. Lux G, Rebasti F. L-Glutamic acid and L-lysine as useful building blocks for the preparation of bifunctional DTPA-like ligands, Bioconj Chem 1999;10:137–40.
Eckelman WC, Karesh SM, Rcba RC. New compounds: fatty acid and long chain hydrocarbon derivatives containing a strong chelating agent. J Pharm Sci 1975;64:704–6.
Anelli PL, Lattuada L, Uggeri F, Lux G, Serleti M. Gabellini M. Tournier H. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents. PCT Int Appl WO00/30688, 2000; June 2.
Rudkevich DM, Verboom W, Brzozka Z, Palys MJ, Stauthamer WPRV, van Hummel GJ, Franken SM, Harkema S, Engbersen JFJ, Reinhoudt DN. Functionalized UO2 salenes: neutral receptors for anions. J Am Chem Soc 1994;116:4341–51.
Tundo P, Kippenberger DJ, Politi MJ, Klahn P, Fendler JH. Redox active functionally polymerized surfactant vesicles. Syntheses and characterization. J Am Chem Soc 1982; 104:5352–8.
Wissmann H, Kleiner H-J. New peptide synthesis. Angew Chem Int Ed Engl 1980;19:133–4.
Lasic L, Martin F. Stealth Liposomes. Boca Raton, FL: CRC Press, 1995.
Kondo T. Mechanisms of hemolysis by surface active agents. Adv Coll Interface Sci 1976;6:139–72.
Jayasuriya N, Bosak S, Regen SL. Design, synthesis and activity of membrane-disrupting bolaphiles. J Am Chem Soc 1990; 112:5844–50.
Jasanada F, Nepveu F. Synthesis of amphiphilic chelating agents: bis(hexadecylamide) and bis(octadecylamide) of di-ethylenetriaminepentaacetic acid. Tetrahed Lett 1992;33:5745–8.
Bundgaard H. Novel chemical approaches in prodrug design. Drugs Future 1991;16:443–58.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Anelli, P.L., Lattuada, L., Lorusso, V. et al. Mixed micelles containing lipophilic gadolinium complexes as MRA contrast agents. MAGMA 12, 114–120 (2001). https://doi.org/10.1007/BF02668092
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02668092